Activities per year
Activities
- 1 - 50 out of 226 results
Search results
-
Dose-volume predictors of cardiac adverse events after high-dose thoracic radiation therapy for lung cancer: a systematic review and meta-analysis
Locquet, M. (Speaker), Jacob, S. (Speaker), Geets, X. (Speaker) & Beaudart, C. (Speaker)
2 May 2025 → 6 May 2025Activity: Talk or presentation types › Oral presentation
-
Longitudinal changes in inflammatory biomarkers in early coronary artery calcification after breast cancer radiotherapy: the BACCARAT cohort study
Locquet, M. (Speaker), Jimenez, G. (Speaker), Ferrières, J. (Speaker), Lapeyre, M. (Speaker), Allodji S., R. (Speaker), Honaryar, M. K. (Speaker), Camilleri, J. (Speaker), Broggio, D. (Speaker), de Vathaire, F. (Speaker), Fabien, M. (Speaker) & Jacob, S. (Speaker)
2 May 2025 → 6 May 2025Activity: Talk or presentation types › Oral presentation
-
Evaluation of the pragmatism of clinical trials in sarcopenia: a systematic review
Van Heden, S. (Speaker)
12 Apr 2025Activity: Talk or presentation types › Oral presentation
-
Reduced Risk of Venous Thromboembolism with Natural Estrogen-Based COCs Compared to Ethinylestradiol Pills
Raskin, L. (Speaker)
27 Mar 2025Activity: Talk or presentation types › Oral presentation
-
Towards a Core Outcome Set (COS) for Sarcopenia Intervention Studies: A Systematic Review identifying the most reported outcomes across randomized controlled trials in sarcopenia
Van Heden, S. (Speaker)
14 Mar 2025Activity: Talk or presentation types › Oral presentation
-
An in vitro cell based model for testing NETosis inhibitors and proNETotic agents.
Michaux, P. (Speaker), Bouarroudj, H. (Speaker) & Douxfils, J. (Speaker)
27 Mar 2025Activity: Talk or presentation types › Oral presentation
-
Effect of E4/DRSP 15/3 mg on Hemostasis Parameters in Post-Menarchal Adolescents: A Phase 3 Multicentre Study
Douxfils, J. (Speaker)
20 Mar 2025Activity: Talk or presentation types › Oral presentation
-
Dose-volume predictors of cardiac adverse events after high-dose thoracic radiation therapy for lung cancer: a systematic review and meta-analysis
Locquet, M. (Speaker), Jacob, S. (Speaker), Geets, X. (Speaker) & Beaudart, C. (Speaker)
13 Feb 2025Activity: Talk or presentation types › Oral presentation
-
Towards developing a core outcome set for Osteosarcopenia intervention studies
Van Heden, S. (Speaker)
18 Jan 2025Activity: Talk or presentation types › Oral presentation
-
Sweeping LET: Exploring UHDR Irradiation Parameters and FLASH Effect Occurrence on C. elegans and Tumor Spheroids
Heuskin, A.-C. (Speaker)
4 Dec 2024 → 6 Dec 2024Activity: Talk or presentation types › Oral presentation
-
EuroThrombosis & Eurovessels 2024 - Asundexian and milvexian: What impact on the activity of the intrinsic pathway ?
Vassart, J. (Speaker)
12 Oct 2024Activity: Talk or presentation types › Oral presentation
-
Photocurrent generation by PVD-coated complex 3D foams: an experimental & modelling study
Chavee, L. (Speaker), Lucas, S. (Speaker), GRIES, T. (Speaker) & Haye, E. (Speaker)
2 Sept 2024 → 5 Sept 2024Activity: Talk or presentation types › Oral presentation
-
9th EuChemS Chemistry Congress
Leherte, L. (Speaker)
7 Jul 2024 → 11 Jul 2024Activity: Talk or presentation types › Oral presentation
-
Reprogramming tumor-associated macrophages with gold nanoparticle and proton irradiation
Iyer, S. (Speaker)
Jun 2024Activity: Talk or presentation types › Oral presentation
-
Differentiated thyroid cancers risks in French Polynesia: Role of Nuclear tests’
Locquet, M. (Speaker)
7 Mar 2024Activity: Talk or presentation types › Oral presentation
-
Impact de l'estetrol sur la coagulation chez les femmes ménopausées
Didembourg, M. (Speaker)
28 Mar 2024Activity: Talk or presentation types › Oral presentation
-
13ème symposium annuel du Namur Thrombosis and Hemostasis Center (NTHC) - Présentation de "Impact of FXI inhibitors on coagulation testing"
Vassart, J. (Speaker)
28 Mar 2024Activity: Talk or presentation types › Oral presentation
-
Ant-icipating the fallout
Hespeels, B. (Speaker)
29 Mar 2024Activity: Talk or presentation types › Oral presentation
-
Women and girls in Science 2024
Sopbue Kamguem, I. (Speaker)
8 Feb 2024Activity: Talk or presentation types › Oral presentation
-
Growth mechanisms and properties of magnetron sputtered TiO2 thin films on complex 3D foam substrates
Chavee, L. (Speaker), Lucas, S. (Speaker), GRIES, T. (Speaker) & Haye, E. (Speaker)
18 Dec 2023Activity: Talk or presentation types › Oral presentation
-
Prediction of venous thromboembolism risk associated with combined oral contraceptives: an exploratory model
Morimont, L. (Speaker) & Douxfils, J. (Speaker)
30 Nov 2023Activity: Talk or presentation types › Oral presentation
-
Navigating new regulations in biobanking for clinical studies and research projects
Douxfils, J. (Speaker)
4 Oct 2023Activity: Talk or presentation types › Oral presentation
-
GROWTH MECHANISMS AND PROPERTIES OF MAGNETRON SPUTTERED TIO2 THIN FILMS ON COMPLEX 3D FOAM SUBSTRATES
Chavee, L. (Speaker), Lucas, S. (Speaker), GRIES, T. (Speaker) & Haye, E. (Speaker)
11 Sept 2023 → 15 Sept 2023Activity: Talk or presentation types › Oral presentation
-
Reconstruction d'épiderme en milieu animal-free
Poumay, Y. (Speaker)
16 Jun 2023Activity: Talk or presentation types › Oral presentation
-
Caractérisation de la composition et de la régulation du sécrétome des kératinocytes sénescents
Bouriez, I. (Speaker)
15 Jun 2023Activity: Talk or presentation types › Oral presentation
-
Fantastic 4 - E4stetrol in Women's Health
Douxfils, J. (Invited speaker) & Foidart, J.-M. (Invited speaker)
4 May 2023 → 6 May 2023Activity: Talk or presentation types › Oral presentation
-
Prediction Of Venous Thromboembolism Risk Associated With Combined Oral Contraceptives: An Exploratory Model
Morimont, L. (Speaker)
19 May 2023Activity: Talk or presentation types › Oral presentation
-
NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study
Morimont, L. (Speaker)
27 Apr 2023Activity: Talk or presentation types › Oral presentation
-
Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Douxfils, J. (Invited speaker)
24 Mar 2023Activity: Talk or presentation types › Oral presentation
-
Ma thèse en 180 secondes
Hardy, E. (Speaker)
24 Mar 2023Activity: Talk or presentation types › Oral presentation
-
Introduction à la bioéthique et liens avec la périnatalité
Ravez, L. (Speaker)
16 Nov 2022Activity: Talk or presentation types › Oral presentation
-
Éthique de la dentisterie
Ravez, L. (Speaker)
24 Nov 2022Activity: Talk or presentation types › Oral presentation
-
L'éthique au service de la pratique
Ravez, L. (Speaker)
15 Nov 2022Activity: Talk or presentation types › Oral presentation
-
Bioéthique, consumérisme et imagerie médicale
Ravez, L. (Speaker)
1 Oct 2022Activity: Talk or presentation types › Oral presentation
-
Radiation resistance and DNA repair following exposure to desiccation and ionizing radiation are ancient and universal features in bdelloid rotifers: a new model for space research?
Hespeels, B. (Speaker)
8 Oct 2022Activity: Talk or presentation types › Oral presentation
-
Les soins de santé face au changement climatique : penser autrement l'autonomie
Ravez, L. (Speaker)
26 Oct 2022Activity: Talk or presentation types › Oral presentation
-
Éthique et santé publique
Ravez, L. (Speaker)
21 Oct 2022Activity: Talk or presentation types › Oral presentation
-
Faut-il arrêter la consommation d’éthique passé un certain âge ?
Ravez, L. (Speaker)
21 Oct 2022Activity: Talk or presentation types › Oral presentation
-
Rotifers In SpacE (RISE)
Hespeels, B. (Speaker)
20 Oct 2022Activity: Talk or presentation types › Oral presentation
-
Low thrombin generation in menopausal women using Estetrol (E4)
Morimont, L. (Speaker)
27 Oct 2022Activity: Talk or presentation types › Oral presentation
-
Low Thrombin Generation in Menopausal Women Using Estetrol (E4)
Morimont, L. (Speaker) & Douxfils, J. (Speaker)
26 Oct 2022Activity: Talk or presentation types › Oral presentation
-
The mechanisms governing oxidation resistance, structural and mechanical behaviour of TiAlN coatings between 600°C and 800°C
Chavee, L. (Speaker), Serag, E. S. T. (Speaker), Da Silva Pires, M. (Speaker), Lucas, S. (Speaker) & Haye, E. (Speaker)
12 Sept 2022 → 15 Sept 2022Activity: Talk or presentation types › Oral presentation
-
De la poudre d'or pour le traitement du cancer
Heuskin, A.-C. (Speaker)
23 Aug 2022Activity: Talk or presentation types › Oral presentation
-
Description of chalcogen interactions in smoothed Cromer-Mann electron density distributions
Leherte, L. (Speaker)
19 Jul 2022Activity: Talk or presentation types › Oral presentation
-
Affinity Capillary Electrophoresis in Fragment-Based Drug Discovery Projects, a Tool for Hit Discovery and Binding Site Characterization
DAVOINE, C. (Speaker)
4 Jul 2022Activity: Talk or presentation types › Oral presentation
-
Quelle universalité pour la bioéthique
Ravez, L. (Speaker)
7 Jun 2022Activity: Talk or presentation types › Oral presentation
-
Undermining MPV17 function through BioID-based characterization of its proxisome
MEURANT, S. (Speaker)
15 May 2022 → 19 May 2022Activity: Talk or presentation types › Oral presentation
-
Estetrol (E4): a native estrogen whose effect on the liver does not need to be counterbalanced by progestins
Douxfils, J. (Speaker)
27 May 2022Activity: Talk or presentation types › Oral presentation
-
Unravelling the molecular mechanisms of clathrin-independent endocytosis to elucidate its pathophysiological functions
Renard, H.-F. (Speaker)
16 May 2022 → 20 May 2022Activity: Talk or presentation types › Oral presentation
-
L’éthique à l’hôpital? Cessons donc d’être efficaces!
Ravez, L. (Speaker)
10 May 2022Activity: Talk or presentation types › Oral presentation